eMAX Health Systems

What eMAX Health Systems does

eMAX Health Systems is a privately held healthcare services and technology company that connects market access strategy, real-world evidence, patient services workflow, and pharmacy infrastructure for pharmaceutical manufacturers and emerging biotech companies. Founded in 2004 and headquartered in Delray Beach, Florida, the company operates through three integrated divisions — eMAX Health Systems (market access strategy, HEOR, pricing & contracting), eMAX Health Patient Services (hub execution, reimbursement support, affordability programs), and eMAX Health Pharmacy (non-commercial dispensing for bridge and patient assistance programs). The legal entity is eMAX Health 2.0 LLC, and the company reports serving Top 20 pharmaceutical organizations alongside emerging biotech clients across oncology, rare disease, immunology, CNS, and specialty therapeutic areas.

The company’s technology backbone consists of four proprietary, trademarked platforms: MAVA® (real-time stakeholder engagement with payers, providers, and channel intermediaries), EMRClaims+® (integrated EMR + claims data platform covering 58M+ healthcare encounters for real-world evidence generation), HealthPACER® (patient services workflow management), and HealthPACER® AI (AI-driven workflow automation and patient engagement prioritization). The MAVA® platform also hosts analytical sub-modules — Elasticity™ for pricing sensitivity modeling and Contracting ROI for rebate and contract performance evaluation. The integrated architecture is designed to eliminate fragmentation across the access journey by connecting strategy, evidence, and program operations on shared data foundations.

eMAX Health generates revenue through two primary streams: subscription/licensing of its proprietary technology platforms (MAVA, EMRClaims+, HealthPACER, HealthPACER AI) to pharma and biotech organizations, and professional services/consulting revenue tied to market access strategy development, evidence generation, pricing and contracting advisory, patient services program design, and pharmacy infrastructure setup. Pricing is not publicly disclosed; the enterprise sales motion is consultative, with "Request a Demo" and "Schedule a Capabilities Discussion" CTAs suggesting multi-year contracts negotiated on a per-engagement basis. The company supports demand generation through content marketing (insights blog), webinars such as "The Access Inflection," LinkedIn presence, and email campaigns via Mailchimp, while its customer base spans enterprise pharmaceutical manufacturers and innovative biotech companies across all 50 U.S. states.

Name

eMAX Health Systems

Legal name

eMAX Health 2.0 LLC

Website

https://emaxhealth.net

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

eMAX Health Systems connects market access strategy, real-world evidence, patient services workflow, and non-commercial pharmacy infrastructure for pharmaceutical manufacturers and emerging biotech companies through proprietary platforms MAVA®, EMRClaims+®, and HealthPACER®.

Ownership category

akta.pro rank

Product category

Life Sciences Market Access Software & Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Services-Prepackaged Software (7372), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Services-Health Services (8000)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industries

Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools (HLACAKAH), Medication Pricing, Copay Assistance & Patient Financial Support Tools (HLACAKAN), Medication Adherence & Therapy Management Platforms (refills, reminders, MTM) (HLALAIAG)

Keywords

• Market access software
• Real-world evidence platform
• Patient services workflow
• Pharmaceutical consulting services
• Life sciences SaaS

Headquarters

HQ city

Delray Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Platform/SaaS Licensing: Proprietary platforms (MAVA, EMRClaims+, HealthPACER, HealthPACER AI) likely offered as licensed technology solutions to pharmaceutical and biotech organizations. Platforms are marketed with clear brand identities and capabilities descriptions suggesting commercial licensing model.
2. Professional Services & Consulting: Strategic consulting services across market access strategy, real-world evidence development, pricing and contracting, patient services program design, and pharmacy infrastructure. The company provides customized market access strategy development, evidence generation, and execution support suggesting professional services revenue.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

eMAX Health Systems sells proprietary SaaS platforms (MAVA®, EMRClaims+®, HealthPACER®, HealthPACER® AI) and related analytical modules (Elasticity™, Contracting ROI) that connect market access strategy, real-world evidence, patient services workflow, and pharmacy infrastructure for pharmaceutical and biotech manufacturers. The company complements these platforms with professional services spanning market access strategy, HEOR/RWE, pricing and contracting, patient services program design, and non-commercial dispensing pharmacy infrastructure.

Product overview

eMAX Health Systems offers a platform-plus-modules architecture consisting of three integrated business units: eMAX Health Systems (market access strategy and real-world evidence), eMAX Health Patient Services (hub execution and patient support), and eMAX Health Pharmacy (non-commercial dispensing infrastructure). The core technology portfolio includes MAVA® for real-time stakeholder engagement, EMRClaims+® for integrated EMR and claims data analytics, HealthPACER® for patient services workflow management, and HealthPACER® AI for AI-driven workflow automation. Additional analytical modules within MAVA® include Elasticity™ (pricing sensitivity analysis) and Contracting ROI (contract performance evaluation). The integrated approach connects market access strategy, real-world evidence, patient services, and pharmacy infrastructure for life sciences organizations.

Differentiator

Problem solved

Functional benefit

Brands

• MAVA®: Real-time stakeholder engagement platform for market access strategy and payer/provider insights
• EMRClaims+®
• HealthPACER®
• HealthPACER® AI
• Elasticity™
• Contracting ROI

Products and services

• MAVA® Real-time stakeholder engagement platform that generates actionable insight to inform market access strategy through structured engagement with payer, provider, patient, and channel intermediary stakeholders; supports pricing, contracting, and access strategy decisions for pharmaceutical and biotech teams.
• EMRClaims+® Integrated EMR and claims data platform connecting electronic medical record data with longitudinal claims insight to analyze prescribing patterns, treatment pathways, and patient outcomes across 58M+ healthcare encounters, supporting real-world evidence generation and patient cohort development for life sciences teams.
• HealthPACER® Patient services workflow platform that manages enrollment, reimbursement support, affordability programs, and patient engagement through role-specific dashboards and real-time case visibility across benefit investigations, prior authorizations, appeals, and patient assistance program workflows for pharmaceutical and biotech teams.
• HealthPACER® AI AI-driven capabilities that automate workflows, prioritize patient engagement, and expand operational capacity across patient services programs, built as an AI extension of the HealthPACER® platform.
• eMAX Health Patient Services Operating division delivering tech-enabled patient services and hub execution for pharmaceutical and biotech teams, including reimbursement support, affordability programs, adherence programs, and hub model design, powered by the HealthPACER® platform.
• eMAX Health Pharmacy Non-commercial dispensing pharmacy infrastructure that supports bridge, patient assistance, and direct-to-patient access programs with compliant access pathways, integrating with patient services to maintain therapy continuity and operational visibility.
• eMAX Health Systems Consulting Consulting practice delivering market access strategy, HEOR/real-world evidence, pricing and contracting strategy, and value communication services for pharmaceutical and biotech manufacturers, leveraging the MAVA® platform and EMRClaims+® data assets.

Quantifiable outcome

• 5,000+ payer and provider stakeholders engaged
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• EVERSANA: EVERSANA is a large life sciences commercial services platform offering market access, patient services, RWE, and pharmacy services — directly overlapping eMAX Health's three-pillar model and serving the same Top 20 pharma and emerging biotech buyer base.
• Precision AQ: Precision AQ is a market access and payer pull-through consultancy that overlaps directly with eMAX Health Systems' strategy and pricing/contracting work, and counts similar Top 20 pharma clients among its customers.
• Avalere Health: Avalere Health is a healthcare strategy and policy consultancy offering market access, evidence, and value-based contracting services to pharma and biotech — directly comparable to eMAX's market access and HEOR practice.
• Norstella (MMIT / Evaluate): Norstella, including MMIT, provides market access data, payer intelligence, and analytics used by pharma market access teams — directly comparable to eMAX's MAVA® stakeholder engagement and access strategy capabilities.
• The Access Group: The Access Group is a pharma-specific managed markets and market access consultancy with overlapping service scope to eMAX Health Systems, and is a prior employer of eMAX's President.

Broad incumbents

• IQVIA: IQVIA is the global incumbent in healthcare data, real-world evidence, and market access analytics. Its RWE and market access franchises compete head-to-head with eMAX's MAVA® and EMRClaims+® offerings while offering far broader data assets.
• Syneos Health: Syneos Health provides biopharma commercial and clinical solutions including market access, patient services, and evidence generation. It is a scaled incumbent in the same buyer segment as eMAX Health with overlapping solution scope.
• ZS Associates: ZS Associates is a major management consultancy with a dedicated pharma practice covering market access, pricing, and patient strategy — competing for the same Top 20 pharma access strategy engagements as eMAX Health Systems.
• Cencora (formerly AmerisourceBergen) PharmaLex: Cencora's PharmaLex / World Courier / consulting arms offer market access, patient services, and specialty distribution services that overlap with eMAX Health's patient services hub and pharmacy infrastructure offerings.
• Veeva Systems: Veeva is the dominant SaaS vendor for life sciences commercial and medical affairs teams, including market access, and represents an incumbent software competitor that eMAX's MAVA® and HealthPACER® platforms compete against for technology budget.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/emax-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries3 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about eMAX Health Systems